Insider Trading History of Passeri Daniel R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Passeri Daniel R since year 2005. The trader's CIK number is 1190121. At the time of the last reporting, Passeri Daniel R was the CEO and President of Cue Biopharma, Inc. . (stock ticker symbol CUE). See this page for all insider trading activities at Cue Biopharma, Inc. .

Note that in the past PASSERI DANIEL R also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Passeri Daniel R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-06 CUE Cue Biopharma, Inc. Buy 3,000 6.90 20,700
2018-08-16 CUE Cue Biopharma, Inc. Buy 6,000 8.09 48,510
2018-06-29 CUE Cue Biopharma, Inc. Buy 1,600 11.97 19,152
2016-01-06 CRIS Curis Inc Option Ex 12,900 1.57 20,253
2015-12-30 CRIS Curis Inc Sale 14,400 3.01 43,344
2015-12-29 CRIS Curis Inc Sale 11,200 2.91 32,592
2015-12-30 CRIS Curis Inc Option Ex 14,400 1.57 22,608
2015-12-29 CRIS Curis Inc Option Ex 11,200 1.57 17,584
2015-12-28 CRIS Curis Inc Sale 11,000 2.84 31,240
2015-12-28 CRIS Curis Inc Option Ex 11,000 1.57 17,270
2015-12-24 CRIS Curis Inc Sale 2,600 2.90 7,540
2015-12-24 CRIS Curis Inc Option Ex 2,600 1.57 4,082
2015-12-23 CRIS Curis Inc Option Ex 10,900 1.57 17,113
2015-12-22 CRIS Curis Inc Sale 38,000 2.75 104,500
2015-12-23 CRIS Curis Inc Sale 10,900 2.90 31,610
2015-12-22 CRIS Curis Inc Option Ex 38,000 1.57 59,660
2015-12-21 CRIS Curis Inc Sale 100,000 2.87 287,000
2015-12-18 CRIS Curis Inc Option Ex 189,000 1.57 296,730
2015-12-18 CRIS Curis Inc Sale 189,000 3.05 576,450
2015-12-21 CRIS Curis Inc Option Ex 100,000 1.57 157,000
2013-05-06 CRIS Curis Inc Sale 60,000 3.66 219,600
2013-05-06 CRIS Curis Inc Option Ex 262,667 2.43 638,280
2013-05-03 CRIS Curis Inc Sale 65,000 3.73 242,450
2013-05-02 CRIS Curis Inc Sale 50,000 3.66 183,000
2013-05-03 CRIS Curis Inc Option Ex 65,000 2.43 157,950
2013-05-02 CRIS Curis Inc Option Ex 50,000 2.43 121,500
2012-12-06 CRIS Curis Inc Buy 25,000 3.03 75,750
2012-04-30 CRIS Curis Inc Sale 74,650 4.83 360,559
2012-05-01 CRIS Curis Inc Sale 36,000 4.80 172,800
2012-04-30 CRIS Curis Inc Option Ex 74,650 1.29 96,671
2012-05-01 CRIS Curis Inc Option Ex 36,000 1.09 39,240
2012-03-20 CRIS Curis Inc Option Ex 60,750 1.29 78,671
2011-03-30 CRIS Curis Inc Option Ex 26,900 3.13 84,197
2011-03-31 CRIS Curis Inc Option Ex 98,100 3.13 307,053
2011-03-30 CRIS Curis Inc Sale 26,900 3.27 87,963
2011-03-31 CRIS Curis Inc Sale 98,100 3.25 318,825
2008-10-01 CRIS Curis Inc Option Ex 20,000 1.09 21,800
2008-08-07 CRIS Curis Inc Buy 20,000 1.55 31,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Passeri Daniel R (CEO and President of Cue Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.